Home/DendroTEK Biosciences/Jean‑Pierre Clément
JC

Jean‑Pierre Clément

Co‑Founder / CEO

DendroTEK Biosciences

Therapeutic Areas

DendroTEK Biosciences Pipeline

DrugIndicationPhase
dPGA (5 mg, 10 mg, 50 mg)Cell‑culture substrate for neuronal and stem‑cell applicationsN/A